Originally developed to treat people with type-2 diabetes (T2DM), these drugs have proven useful for addressing a range of other conditions, from obesity to sleep apnea
Most are sold without a prescription and contain herbal or supplement ingredients rather than the regulated GLP-1 medication found in prescription injections, which is why the category causes so much confusion
doi: 10.1038/s41598-017-02660-w
A multicenter, randomized, double-blind, placebo-controlled trial demonstrated that liraglutide was associated with the resolution of non-alcoholic steatohepatitis (NASH) without worsening fibrosis
Most data derives from individual peptide research, and human clinical trials for the combination are completely non-existent
The most noticeable difference in whole-brain activity signatures between GLP-1MK-801 and semaglutide was the significantly higher number of cFOS + cells in the nucleus accumbens in response to GLP-1MK-801 compared with semaglutide and vehicle treatment